Etofylline/ Diphenhydramine/ Ammonium Chloride
Indications
Registered South African indications:
- Cough
Cautions
Combination products may have additional pharmacological effects not accounted for by the action of the individual ingredients
Etofylline
Contraindications
- Hypersensitivity to the active ingredient or any of the excipients in this combination product
- Seizure disorders
Cautions
- Pregnancy
- Breastfeeding
- Renal impairment
- Hepatic impairment
- Elderly
- Peptic ulcer disease
- Cardiac disease
- Benign prostatic hypertrophy
- Glaucoma
Diphenhydramine
Contraindications
- Hypersensitivity to the active ingredient or any of the excipients in this combination product
- Asthma
- Closed angle glaucoma
- Prostatic hypertrophy
- Stenosing peptic ulcer
- Pyloroduodenal obstruction
- Bladder neck obstruction
- Porphyria
Cautions
- Breastfeeding
- Moderate to severe renal impairment
- Hepatic impairment
- Elderly
- Glaucoma
- Urinary retention
- Myasthenia gravis
- Epilepsy
- Bronchitis
- Chronic obstructive pulmonary disease
- Tinnitus
- Prolonged use
Ammonium Chloride
Contraindications
- Hypersensitivity to the active ingredient or any of the excipients in this combination product
- Severe renal impairment
- Severe hepatic impairment
- Metabolic alkalosis
Cautions
- Pregnancy
- Breastfeeding
- Mild to moderate renal impairment
- Mild to moderate hepatic impairment
- Respiratory insufficiency
Adult dosage
Forms avail. in SA and covered in this monograph: syr
For the relief of coughing and to facilitate bronchodilation and expectoration
Etofylline/ Diphenhydramine/ Ammonium Chloride
105.5/42.2/410.5 (mg/15ml)
- Oral (syr): 15ml, 6-8hrly
Paediatric dosage
Paed. forms avail. in SA and covered in this monograph: syr
For the relief of coughing and to facilitate bronchodilation and expectoration
Etofylline/ Diphenhydramine/ Ammonium Chloride
105.5/42.2/410.5 (mg/15ml)
- Younger than 2 years: Not established for use
- Between 2-6 years: Oral (syr): 2.5ml, 6-8hrly
- Between 6-12 years: Oral (syr): 5ml, 6-8hrly
- Older than 12 years: See adult dosage
Special populations
Recommendations for this combination product as per highest risk category when comparing individual active ingredients
Pregnancy
Breastfeeding
Renal Impairment
- Mild to moderate: Caution; no information available (Etofylline)
- Severe: Contraindicated (Ammonium chloride)
Hepatic Impairment
- Mild to moderate: Caution; no information available (Etofylline)
- Severe: Contraindicated (Ammonium chloride)
Elderly
Adverse reactions
Combination products may have additional pharmacological effects not accounted for by the action of the individual ingredients
Etofylline
Central Nervous System Disorders
- Insomnia
- Irritability
Cardiovascular Disorders
- Tachycardia
- Palpitations
Gastrointestinal Disorders
- Abdominal pain
- Diarrhoea
- Nausea and vomiting
Diphenhydramine
Central Nervous System Disorders
- Sedation
- Disturbances in attention
- Unsteadiness
- Dizziness
- Seizures
- Headache
- Paraesthesia
- Dyskinesias
- Fatigue
- Confusion
- Paradoxical excitement
Cardiovascular Disorders
- Tachycardia
- Palpitations
Respiratory Disorders
- Dyspnoea
- Thickening of bronchial secretions
Gastrointestinal Disorders
- Dry mouth
- Nausea and vomiting
Genitourinary Disorders
- Urinary difficulty
- Urinary retention
Musculoskeletal Disorders
- Muscle twitching
Immune, Blood and Lymphatic System Disorders
- Hypersensitivity reactions
- Urticaria
- Angioedema
Sensory Disorders
- Blurred vision
- Tinnitus
Ammonium Chloride
Central Nervous System Disorders
- Coma
- Confusion
- Seizures
- Fever
Gastrointestinal Disorders
- Gastrointestinal discomfort
- Nausea and vomiting
Interactions
Combination products may have additional pharmacological effects not accounted for by the action of the individual ingredients
Etofylline
- Central nervous system depressants
- Warfarin
- Sulphonylureas
Diphenhydramine
- Central nervous system depressants
- Monoamine oxidase inhibitors
- Anticholinergic agents
- CYP2D6 substrates
Ammonium Chloride
- Potassium sparing diuretics
Monitoring
None routine
Mechanism of action
Etofylline
Etofylline is N-7 substituted theophylline derivative which acts similar to other xanthines. The bronchodilating action of xanthines is thought to result from the competitive inhibition of phosphodiesterase, which is the enzyme responsible for the breakdown cyclic AMP in smooth muscle cells.
Diphenhydramine
Diphenhydramine is a histamine H1-receptor antagonist that competes with free histamine for binding at histamine receptors. In addition to its usual anti-allergy actions, it also has significant sedative and antimuscarinic properties.
Ammonium Chloride
Ammonium chloride is used as an expectorant. It causes irritation of the bronchial mucosa, which results in the production of excess respiratory tract fluid. This allows for easier mucus expulsion due to its decreased viscosity.
Dosage forms
- Syrup
Formulation
COMBINATION PREPARATIONS
Ammonium Chloride/ Etofylline/ Diphenhydramine
Syrup (per 15ml) 410.5mg/105.5mg/42.2mg
- Dilinct ( Adcock)
References
1. https://drive.google.com/drive/folders/0B27NqM_vidrmNDJURnktVWhVMVU (Adcock_Dilinct_syrup) 2. Individual monographs https://admin.emguidance.com/medicine-edit/b69af425-601f-4575-aba8-c51d8560715b?pageNum=2 https://admin.emguidance.com/medicine-edit/9ebe5ad3-5c86-498f-9da5-98d804f45699?pageNum=2 https://admin.emguidance.com/medicine-edit/118aa5c7-0b1a-4af8-b4a4-c2210d4071d8?pageNum=1
Brands & products
2 products · cached snapshot- Dilinct
SYRSyrup· 2 products
from R48.45| Product | Strength | Pack | Applicant | Min price |
|---|---|---|---|---|
| Dilinct | 105.5 mg/15ml;mg/15ml;mg/15ml | 100 | Adcock Ingram Limited | R48.45 |
| Dilinct | 105.5 mg/15ml;mg/15ml;mg/15ml | 200 | Adcock Ingram Limited | R96.89 |
Medical aid coverage
data not yet integrated- Comprehensive Series—
- Executive Plan—
- KeyCare Series—
- Priority Series—
- Saver Series—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- BonClassic—
- BonComprehensive—
- BonEssential—
- BonFit Select—
- BonSave—
- BonStart—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- Beryl—
- Emerald—
- Onyx—
- Ruby—
- Sapphire—
- Tanzanite One—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- Aquarium Option—
- Efficiency Option—
- Marine Option—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.